| Previous close | 34.17 |
| Open | 34.16 |
| Bid | 33.94 x 100 |
| Ask | 34.39 x 1400 |
| Day's range | 33.97 - 34.21 |
| 52-week range | 29.83 - 37.39 |
| Volume | 14,172,264 |
| Avg. volume | 21,532,439 |
| Market cap | 203.15B |
| Beta | 1.06 |
| PE ratio (TTM) | 28.65 |
| EPS (TTM) | 1.19 |
| Earnings date | 31 Jul 2017 - 4 Aug 2017 |
| Dividend & yield | 1.28 (3.75%) |
| Ex-dividend date | 2017-05-10 |
| 1y target est | 37.35 |
- TheStreet.com•7 hours ago
15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
Here are the names.
- Motley Fool•13 hours ago
How Things Look for Opko Health, Inc. in 3 Charts
It hasn't been a great year so far for Opko Health, but the future could be brighter.
- Market Realist•17 hours ago
Pfizer Has Received Commercial Rights for Cresemba in Europe
On June 14, 2017, Pfizer (PFE) announced an agreement with Basilea Pharmaceutica for exclusive commercial rights for Cresemba in Europe.
